IL268929A - Deliberately selected preparations containing purified cannabinoids and/or purified terpenes - Google Patents
Deliberately selected preparations containing purified cannabinoids and/or purified terpenesInfo
- Publication number
- IL268929A IL268929A IL26892919A IL26892919A IL268929A IL 268929 A IL268929 A IL 268929A IL 26892919 A IL26892919 A IL 26892919A IL 26892919 A IL26892919 A IL 26892919A IL 268929 A IL268929 A IL 268929A
- Authority
- IL
- Israel
- Prior art keywords
- purified
- terpenes
- preparations containing
- cannabinoids
- deliberately selected
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (18)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762465688P | 2017-03-01 | 2017-03-01 | |
| US201762469415P | 2017-03-09 | 2017-03-09 | |
| US201762475153P | 2017-03-22 | 2017-03-22 | |
| US201762477990P | 2017-03-28 | 2017-03-28 | |
| US201762489360P | 2017-04-24 | 2017-04-24 | |
| US201762490567P | 2017-04-26 | 2017-04-26 | |
| US201762490465P | 2017-04-26 | 2017-04-26 | |
| US201762491160P | 2017-04-27 | 2017-04-27 | |
| US201762491175P | 2017-04-27 | 2017-04-27 | |
| US201762491980P | 2017-04-28 | 2017-04-28 | |
| US201762491899P | 2017-04-28 | 2017-04-28 | |
| US201762509651P | 2017-05-22 | 2017-05-22 | |
| US201762510229P | 2017-05-23 | 2017-05-23 | |
| US201762510660P | 2017-05-24 | 2017-05-24 | |
| US201762510672P | 2017-05-24 | 2017-05-24 | |
| US201762511218P | 2017-05-25 | 2017-05-25 | |
| US15/616,874 US20170266153A1 (en) | 2015-02-27 | 2017-06-07 | Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes |
| PCT/US2018/020440 WO2018160827A1 (en) | 2017-03-01 | 2018-03-01 | Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL268929A true IL268929A (en) | 2019-10-31 |
Family
ID=63370542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL26892919A IL268929A (en) | 2017-03-01 | 2019-08-26 | Deliberately selected preparations containing purified cannabinoids and/or purified terpenes |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP3589129A4 (en) |
| CN (1) | CN110582206A (en) |
| AU (1) | AU2018227544A1 (en) |
| BR (1) | BR112019018088A2 (en) |
| CA (1) | CA3054690A1 (en) |
| CO (1) | CO2019009413A2 (en) |
| IL (1) | IL268929A (en) |
| MX (1) | MX2019010370A (en) |
| PE (1) | PE20200383A1 (en) |
| WO (1) | WO2018160827A1 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12458906B2 (en) | 2018-01-23 | 2025-11-04 | High Sierra Technologies, Inc. | Methods of modifying a naturally occurring cannabis raw plant material, a purified cannabis product from a naturally occurring cannabis raw plant material, and a modified cannabis product from a naturally occurring cannabis raw plant material |
| WO2019147690A1 (en) | 2018-01-23 | 2019-08-01 | High Sierra Technologies, Inc. | Cannabis products modified by removing volatile organic compounds and adding volatile unsaturated hydrocarbons |
| IL266151A (en) * | 2019-04-18 | 2019-07-31 | Kanabo Res Ltd | Diluents for compositions of cannabinoids |
| US11925907B2 (en) | 2019-07-22 | 2024-03-12 | Canopy Growth Corporation | Continuous crystallization of cannabinoids in a stirred-tank reactor |
| BR112022010288A2 (en) * | 2019-11-26 | 2022-09-27 | Lycored Ltd | SYNERGIC ANTI-INFLAMMATORY COMBINATIONS OF CANABINOID AND LYCOPENE |
| CN115605289A (en) * | 2020-04-29 | 2023-01-13 | 利加尔有限合伙公司（Nz） | Imprinted polymers and methods of use |
| WO2022020944A1 (en) * | 2020-07-27 | 2022-02-03 | Canopy Growth Corporation | Methods of synthesizing cannabielsoin and analogs thereof |
| US20240342197A1 (en) * | 2021-01-29 | 2024-10-17 | The Johns Hopkins University | Limonene effects on tetrahydrocannabinol (thc)-induced anxiety |
| CN113368086B (en) * | 2021-08-11 | 2021-12-03 | 龙麻(上海)医药研发有限责任公司 | Cannabinoid composition and its application in preparation of medicine for treating neurodegenerative diseases such as Parkinson and Alzheimer |
| US20250367220A1 (en) * | 2022-06-17 | 2025-12-04 | New Growth Brands, Inc. | Compositions comprising cannabinoids and methods of preparation and use thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102009019322A1 (en) * | 2009-04-30 | 2010-11-11 | The Health Concept Gmbh | Process for the preparation of synthetic cannabinoids |
| GB2478595B (en) * | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
| TWI583374B (en) * | 2010-03-30 | 2017-05-21 | Ｇｗ伐瑪有限公司 | Use of plant cannabinoid cannabinol (CBDV) for the treatment of epilepsy |
| ES2784229T3 (en) * | 2013-11-20 | 2020-09-23 | Panag Pharma Inc | Compositions and procedures for the treatment of eye inflammation and pain |
| BR112017018316A2 (en) * | 2015-02-27 | 2018-04-17 | Ebbu Llc | compositions comprising combinations of purified cannabinoids with at least one flavonoid, terpene or mineral |
-
2018
- 2018-03-01 WO PCT/US2018/020440 patent/WO2018160827A1/en not_active Ceased
- 2018-03-01 PE PE2019001790A patent/PE20200383A1/en unknown
- 2018-03-01 CA CA3054690A patent/CA3054690A1/en active Pending
- 2018-03-01 CN CN201880028815.7A patent/CN110582206A/en active Pending
- 2018-03-01 AU AU2018227544A patent/AU2018227544A1/en not_active Abandoned
- 2018-03-01 BR BR112019018088-5A patent/BR112019018088A2/en not_active Application Discontinuation
- 2018-03-01 EP EP18760302.2A patent/EP3589129A4/en not_active Withdrawn
- 2018-03-01 MX MX2019010370A patent/MX2019010370A/en unknown
-
2019
- 2019-08-26 IL IL26892919A patent/IL268929A/en unknown
- 2019-08-29 CO CONC2019/0009413A patent/CO2019009413A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3054690A1 (en) | 2018-09-07 |
| EP3589129A4 (en) | 2020-11-25 |
| AU2018227544A1 (en) | 2019-08-29 |
| CO2019009413A2 (en) | 2019-09-09 |
| EP3589129A1 (en) | 2020-01-08 |
| BR112019018088A2 (en) | 2020-03-24 |
| MX2019010370A (en) | 2019-10-22 |
| WO2018160827A1 (en) | 2018-09-07 |
| CN110582206A (en) | 2019-12-17 |
| PE20200383A1 (en) | 2020-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL268929A (en) | Deliberately selected preparations containing purified cannabinoids and/or purified terpenes | |
| IL286693A (en) | Combined stress response modulator compounds, preparations containing them and their uses | |
| IL279897A (en) | Fusosome preparations and their uses | |
| IL262505B (en) | Preparations containing herbal substances and their uses | |
| IL272089B1 (en) | Compounds, preparations and methods | |
| MA50486A (en) | CANNABINOID EXTRACTION AND DISTILLATION | |
| PL3688162T3 (en) | PREPARATIONS | |
| EP3703672A4 (en) | CANNABINOID FORMULATIONS | |
| IL263901B (en) | Cannabinoid formulations | |
| IL263676A (en) | Methods and preparations for reducing oxidative stress | |
| EP3625774C0 (en) | AUGMENTED REALITY | |
| PL3429580T3 (en) | CANNABINOID COMPOSITION ENRICHED WITH TERPENES | |
| IL247262B (en) | Preparations containing cannabinoids and their uses | |
| IL268684A (en) | Preparations and methods for immuno-oncology | |
| EP3599831A4 (en) | ISOLATION OF PURE CANNABINOIDS FROM CANNABIS | |
| EP3538078A4 (en) | FORMULAS FOR THE EFFICIENT ADMINISTRATION OF CANNABINOIDS | |
| EP3565516A4 (en) | INFUSION SYSTEM AND COMPONENTS THEREOF | |
| IL256260B (en) | Terpanstinil derivatives and preparations containing them and their uses | |
| EP3478308A4 (en) | CANNABIS COMPOSITIONS AND PROCEDURES | |
| IL270799A (en) | Preparations containing myrcan and cannabinoid targeting TRPV1 | |
| IL272200A (en) | Isochromane compounds and their use | |
| IL272375A (en) | Medical Cannabis | |
| EP3351533A4 (en) | BIARYL DERIVATIVE AND MEDICINE CONTAINING THE SAME | |
| EP3511407A4 (en) | CHRISTENSENELLA INTESTINIHOMINIS AND ITS APPLICATION | |
| DK3672948T3 (en) | PYRIDINAMINE-PYRIDONE AND PYRIMIDINAMINE-PYRIDONE COMPOUNDS |